Compare
Amphstar Pharmaceuticals vs Lilly (Eli) (AMPH vs LLY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amphstar Pharmaceuticals (AMPH) returned +12.6% and Lilly (Eli) (LLY) +46.2%; so far this year the figures are +6.4% and +26.0%.
Lilly (Eli) is the larger company by market value, about 1044.1 times the size of Amphstar Pharmaceuticals.
On trailing earnings, AMPH trades at 13.0 times and LLY at 43.9 times.
Revenue grew +3.1% at AMPH and +45.5% at LLY over the last year.
AMPH pays no dividend. LLY yields 0.49%.
Data as of the latest close. Not investment advice.
Relative performance
| AMPH | LLY | |
|---|---|---|
| Price | $28.49 | $1,354.00 |
| 1-day | +3.00% | -0.79% |
| YTD | +6.39% | +25.99% |
| 1 year | +12.56% | +46.25% |
| 3 years | -37.30% | +144.20% |
| Market cap | $1.2B | $1.27T |
| P/E | 13.0 | 43.9 |
| P/S | 1.63 | 14.73 |
| P/B | 1.49 | 31.63 |
| Revenue growth | +3.10% | +45.50% |
| EPS growth | -3.10% | +50.70% |
| Gross margin % | 46.8 | 83.6 |
| Net margin % | 13.3 | 31.9 |
| ROE % | 12.1 | 68.5 |
| Debt / equity | 0.75 | 1.23 |
| FCF yield % | 11.4 | 2.4 |
| Dividend yield % | — | 0.49 |
| Beta | 0.55 | 0.29 |
| RSI (14) | 66.7 | 61.1 |
| Technical rating |